idarubicin has been researched along with l 743,872 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colburn, DE; Giles, FJ; Oladovich, D; Smith, JA | 1 |
| Caballero, D; Mateos, JJ; Perez, E; San Miguel, JF; Sanz-Rodriguez, C; Vazquez, L | 1 |
| Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W | 1 |
1 review(s) available for idarubicin and l 743,872
| Article | Year |
|---|---|
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.
Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole | 2008 |
2 other study(ies) available for idarubicin and l 743,872
| Article | Year |
|---|---|
In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin.
Topics: Acute Disease; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Caspofungin; Cytarabine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Drug Interactions; Echinocandins; Humans; Idarubicin; Itraconazole; Leukemia, Myeloid; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Substrate Specificity | 2004 |
Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Combined Modality Therapy; Cytarabine; Debridement; Diplopia; Drug Therapy, Combination; Echinocandins; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mitoxantrone; Opportunistic Infections; Orbital Diseases; Peptides, Cyclic; Sinusitis; Zygomycosis | 2005 |